/cdn.vox-cdn.com/uploads/chorus_asset/file/25137984/Hulu_on_Disney_Beta_Homepage_1_1440x904.png)
Tag: Wegovy
SpaceX Starship version 2, dog life extension and more science news of the week
If you told someone on the street in the 1970s that humans would no longer have a base on the Moon by the year 2000,
Wegovy/Semaglutide can reduce alcohol dependence, not just weight
A study published this week suggests that semaglutide, the active ingredient in the popular obesity drug Wegovy, may also help people struggling with alcohol use
Novo Nordisk, maker of Wegovy, to spend more than $2 billion to boost production in France
Pharmaceutical giant Novo Nordisk announced it would invest more than 16 billion Danish crowns ($2.34 billion) in its French production site to meet growing demand
Novo Nordisk’s Wegovy Has Heart Benefits Beyond Weight Loss, New Data Suggests
The effectiveness of Novo NordiskIt is Wegovy’s blockbuster obesity treatment in reducing heart attacks and strokes may be due to more than just weight loss,
Wegovy reduces risk of heart attack and stroke in landmark trial
The current trial was sponsored by Novo Nordisk, the maker of Wegovy and Ozempic, and followed patients for two years around the world. Half of
Weight loss drug Wegovy may reduce heart attack risk in some, study finds
Crucial new study suggests weight loss drug Wegovy reduces risk of heart attack, stroke or death from cardiovascular problems by 20% in overweight or obese
FDA approves weight-loss drug Zepbound, a rival to Wegovy and Ozempic
The blockbuster weight loss drug Wegovy has a new rival. Today, the United States Food and Drug Administration approved a new weight management drug called
FDA approves new obesity drug Tirzepatide, which will compete with Wegovy
The Food and Drug Administration on Wednesday approved an obesity drug from the company Eli Lilly that will be a direct competitor to the popular
FDA approves Zepbound from Eli Lilly, a competitor to Wegovy
There’s officially a new, fierce competitor to Novo Nordisk’s Wegovy (semaglutide) when it comes to weight loss. On Wednesday, the Food and Drug Administration approved